Carroll Financial Associates’s Nutrien NTR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q4
$150K Sell
1,995
-340
-15% -$23.8K 0.01% 440
2021
Q3
$151K Sell
2,335
-25
-1% -$1.53K 0.01% 450
2021
Q2
$143K Buy
2,360
+147
+7% +$8.7K 0.01% 497
2021
Q1
$119K Buy
2,213
+1
+0% +$54 0.01% 520
2020
Q4
$106K Buy
2,212
+1
+0% +$44 0.01% 509
2020
Q3
$86K Sell
2,211
-466
-17% -$17K 0.01% 508
2020
Q2
$85K Buy
2,677
+443
+20% +$15.4K 0.01% 507
2020
Q1
$75K Sell
2,234
-291
-12% -$11.6K 0.01% 482
2019
Q4
$121K Sell
2,525
-147
-6% -$7.1K 0.01% 466
2019
Q3
$133K Sell
2,672
-171
-6% -$8.73K 0.01% 445
2019
Q2
$152K Buy
2,843
+284
+11% +$14.8K 0.01% 403
2019
Q1
$135K Buy
2,559
+1,097
+75% +$57.2K 0.01% 387
2018
Q4
$69K Sell
1,462
-100
-6% -$5.21K 0.01% 442
2018
Q3
$90K Buy
1,562
+23
+1% +$1.27K 0.01% 415
2018
Q2
$83K Buy
+1,539
New +$76.3K 0.01% 421

Other funds holding NTR

Carroll Financial Associates's NTR Position: Q4 2021 in Review

Carroll Financial Associates reduced its Nutrien (NTR) stake by 15% in Q4 2021, selling an estimated $23.8K and leaving 1,995 shares worth $150K. The position accounts for 0.01% of the portfolio, ranked #440.

Carroll Financial Associates first reported a position in NTR in Q2 2018 and has held it in 15 quarters since. The position peaked at $152K in Q2 2019. 665 funds tracked by Wall St. Rank hold NTR as of Q4 2021.

  • Carroll Financial Associates held 1,995 shares of Nutrien worth $150K as of Q4 2021.
  • Carroll Financial Associates sold 340 Nutrien shares in Q4 2021, an estimated $23.8K.
  • Nutrien made up 0.01% of Carroll Financial Associates's portfolio in Q4 2021, its #440 holding.
  • Carroll Financial Associates first reported a position in Nutrien in Q2 2018 and has held it in 15 quarters since.
  • Carroll Financial Associates's Nutrien position peaked at $152K in Q2 2019.
  • 665 funds tracked by Wall St. Rank held Nutrien as of Q4 2021.

Based on Carroll Financial Associates's 13F filing for Q4 2021, filed 6 Jan 2022.